In Other News

• Thermo Fisher Collaborates with Artificial to Accelerate COVID-19 Diagnostics

• GE Healthcare’s New Wireless Pocket-Sized Ultrasound Enables Quick Lung Scans of COVID-19 Patients at POC

• Small Device Has Big Implications for COVID-19 Monoclonal Antibody Treatments

• Eurofins Launches Upgraded RT-PCR Kit for Identification of Mutations Associated With SARS-CoV-2 Variants of Concern

• Low Cost Pinprick COVID-19 Test Detects SARS-CoV-2 Antibodies in Drop of Blood in Under an Hour

• New Ultra-Absorptive Nanofiber Swabs Could Improve COVID-19 Test Sensitivity

• Automated System for SARS-CoV-2 Analysis in Wastewater to Enable Early Detection of COVID-19 Prevalence and Mutants

• AI-Powered COVID-19 Solution to Analyze Chest-CT Scans Reduces Turnaround Time, Finds Large-Scale Study

• Targeting New Antibody Supersite Key to COVID-19 Immunity

• Ultrasound Waves at Medical Imaging Frequencies Can Damage SARS-CoV-2 and Could Treat COVID-19

• Aspirin’s Lung-Protective Effects Could Decrease Ventilation, ICU Admission and Death in COVID-19 Patients

• BioMérieux BIOFIRE Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 Becomes First COVID-19 Diagnostic Test to Obtain De Novo FDA Authorization

• Direct, Cost-Effective COVID-19 Tests Identify UK/South African SARS-CoV-2 Variant and Reduces Test Time from Days to Hours

• Insights Into Never-Before Characterized Mechanism of Immune Activation Could Pave Way for Anti-COVID-19 Therapies

• Rapid Saliva-Based Test for COVID-19 Antibodies Could Scale Up Testing to Track Spread of SARS-CoV-2

• Roche Launches New SARS-CoV-2 Variant Test to Monitor Emerging Coronavirus Mutations

• Advanced Machine Learning Algorithm Accurately Predicts Risk of COVID-19 Progressing to Severe Disease or Death

• Snibe Diagnostic SARS-CoV-2 Antigen Assay Secures CE Mark

• New Saliva-Based COVID-19 Test is Less Invasive, More Accessible and Delivers Accurate Results at Lower Cost

• Non-Invasive Skin Swab Samples Enough to Quickly Detect COVID-19, Finds New Study

• Blocking Folate Metabolism with Oral, Prophylactic Drugs Could Reduce Viral Replication in SARS-CoV-2 Infected Cells

• Fujifilm Launches Highly-Sensitive, Rapid CE-Marked SARS-CoV-2 Antigen Test Based on Silver Halide Amplification Technology

• New Compound Reduces Overactive Immune Response Linked to Severe COVID-19 Infections